Angelina I. Makaye

Ms. Angelina I. Makaye


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2025 in In Silico Pharmacology
Verified
Journal Article
Closed access
PDF file
AMAngelina I. Makaye
Angelina I. Makaye
LPLucas Paul
Lucas Paul
SVSaid A. H. Vuai
Said A. H. Vuai
DSDaniel Madulu Shadrack
Daniel Madulu Shadrack

4 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Yoshua Bonface MtuloYoshua Bonface Mtulo
Yoshua Bonface Mtulo
AMAngelina I. Makaye
Angelina I. Makaye
Fidele Ntie-KangFidele Ntie-Kang
Fidele Ntie-Kang
LPLucas Paul
Lucas Paul
The continuous emergence of SARS-CoV-2 variants necessitates the identification of effective multi-target antiviral agents with enhanced stability and binding efficiency. This study employed an integrated computational approach, including molecular docking, molecular dynamics (MD) simulations, free energy landscape (FEL) analysis, and Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) calculations, to evaluate the inhibitory potential of twenty natural compounds against SARS-CoV-2 proteins 7XJW, 8DRW, and 9PFH. Molecular docking identified Amentoflavone as the most promising candidate, exhibiting strong binding affinities toward all targets through favorable hydrogen-bond and hydrophobic interactions within the active sites. Interaction analysis revealed that its biflavonoid scaffold promoted extensive ligand–protein complementarity through hydroxyl and aromatic functional groups. MD simulations demonstrated stable protein-ligand complexes, characterized by low fluctuations in RMSD, RMSF, SASA, and radius of gyration values throughout the 100 ns trajectories. Persistent hydrogen-bond interactions further supported complex stability. FEL analysis revealed compact low-energy conformational basins, indicating thermodynamically favorable binding states. MM-PBSA calculations confirmed favorable binding free energies primarily driven by van der Waals and electrostatic contributions, with the 7XJW-Amentoflavone complex exhibiting the most favorable energetic profile. Overall, these findings highlight Amentoflavone as a promising multi-target inhibitor and potential lead compound for future antiviral drug development and experimental validation against SARS-CoV-2.